RxDoctor Payments Data

Alice Risner

Family · Bellefontaine, OHNPI 1164984746

Payments from drug & device makers

$344in general payments, 2019–2025

Across 18 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$64
  • AbbVie$50
  • Abbott$36
  • Phathom Pharmaceuticals, Inc.$36
  • Actelion Pharmaceuticals US, Inc.$24
  • Seqirus USA Inc$23
  • plus $111 from 6 others

What the payments were for

  • Food & beverage$32494%
  • Other$206%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$344 in reported general payments places this provider in the 50th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$490
Medicare patients
26
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter103$71,386
MounjaroTirzepatide52$52,525
JanuviaSitagliptin Phosphate50$43,533
JardianceEmpagliflozin34$37,431
FarxigaDapagliflozin Propanediol49$35,746
EliquisApixaban47$31,193
TrulicityDulaglutide21$19,721
Spiriva HandihalerTiotropium Bromide17$19,592
OzempicSemaglutide19$18,899
Spiriva RespimatTiotropium Bromide17$14,185
SymbicortBudesonide/Formoterol Fumarate34$12,981
Albuterol Sulfate HfaAlbuterol Sulfate321$8,719
Lantus SolostarInsulin Glargine,hum.Rec.Anlog71$6,295
LinzessLinaclotide12$6,164
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$4,754

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$64$72,24773 claims
PfizerEliquis$20$31,19347 claims
Novo NordiskOzempic$19$18,89919 claims
AbbVieLinzess, Creon$50$10,30123 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,812 family providers in Ohio.

Other family in Bellefontaine

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →